The consequences of doxorubicin quinone reduction in vivo in tumour tissue

This publication has 38 references indexed in Scilit:

• The molecular pharmacology of doxorubicin in vivo
  European Journal of Cancer and Clinical Oncology, 1991
• Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity
  Biochemical Pharmacology, 1990
• Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration
  Cancer, 1988
• Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases
  Nuclear Medicine Communications, 1987
• Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue
  Biochemical Pharmacology, 1987
• Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
  Science, 1984
• The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering Cells
  Science, 1982
• Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA
  Chemico-Biological Interactions, 1979
• Bioactivation as a Model for Drug Design Bioreductive Alkylation
  Science, 1977
• Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin
  Biochemical and Biophysical Research Communications, 1977